JNJ reversing off of Crab pattern. It is hovering over the pervious high of 125.9. If it breaks further, next stops would be 20 MA, -> 0.382 retracement and then 50 MA
Healthcare products maker Johnson & Johnson (NYSE:JNJ) is nearing a double top resistance point on the stock chart. The level is $126 and is the former all-time high on the stock from July 2016. A double top on the stock chart is a technical term that tells investors there will be heavy selling at that point. It likely will be tough for Johnson & Johnson to go...
11% Upside from previous high, target $125
The acquisition of Actelion for 30 mld dollars is a good strike, the EPS for the 2017 are at 6.60 dollars (1.65 dollars for quarter), this equity has a good yield and bright dividend growth prospects. In our view we think that it is a buy stock, with an interesting dividend yeld of 2.85%
This is only a trading capability - no recommendation !!! Buying/Selling or even only watching is always your own responsibility ... .zip (with PDF`s) @ my Google Drive Closings Bearish (Dow Jones Index incl. all shares) drive.google.com Best regards :) Aaron
continues. Stalk your entries.
Hit resistance, looking like it'll probably head towards the lower wedge
TRADE IDEA: Look for a repeat of Pattern 1. With strong support underneath, wait for the break to the upside, and buy on a retrace.
There is no real change in the dominant bear trend, as prices pressure $110.00. Stochastics and sentiment continue to weaken, highlighting further downside risks into the coming weeks. In tandem, Healthcare is also weakening and, along with JNJ, further underperformance relative to the SP500 Index is highlighted.
Seems like it is pulling back, I would prefer to wait for supports to long.